This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Meagan O'Brien
Director of Early Clinical Development and Clinical Experimental Sciences at Regeneron Pharmaceuticals, UK

Profile

Meagan O’Brien is a Director of Early Clinical Development and Clinical Experimental Sciences at Regeneron Pharmaceuticals. Dr. O’Brien received her medical degree from Harvard Medical School and completed medical residency and a fellowship in infectious diseases in New York City at Columbia Presbyterian and New York University Medical Schools. Dr. O’Brien’s NIHsponsored academic research focused on innate immune dysregulation by chronic viral infections and chronic inflammation in HIV infection. Dr. O’Brien joined Regeneron in 2017 to work in Early Clinical development, with a focus on allergy and immunology.

Agenda Sessions

  • Models to Support FiH Studies: Preclinical Efficacy and Toxicity for New Therapeutic Modalities

    09:30